How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.
441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 1 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 2 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| JWY · Manual Antimicrobial Susceptibility Test Systems | 441 | 78 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dalbavancin in the dilution ra…K231988 · JWY | Thermo Fisher Scientific | 510(k) | Aug 30, 2023FDA decision date |
| Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Sulbactam-durlobactam in the dilution range of 0.015/4-32/4 ug/mLK231994 · JWY | Thermo Fisher Scientific | 510(k) | Aug 25, 2023FDA decision date |
| Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC, or Breakpoint Susceptibility System with Imipenem-relebactam in the di…K230935 · JWY | Thermo Fisher Scientific | 510(k) | Jun 30, 2023FDA decision date |
| ComASP Cefiderocol 0.008-128K230479 · JWY | Liofilchem s.r.l. | 510(k) | May 18, 2023FDA decision date |
| Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution r…K223844 · JWY | Thermo Fisher Scientific | 510(k) | Mar 21, 2023FDA decision date |
| ETEST CLINICAL AMIKACIN AK 256 US S30, CATALOG 412218Z-0817-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412240Z-0818-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL AMOXI/CLAV 2/1 XL 256 US S30, CATALOG 412252Z-0819-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL BENZYLPENICIL PG 256 US S30, CATALOG 412262Z-0820-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL CEFTRIAXONE TX 32 US S30, CATALOG 412302Z-0821-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL ERTAPENEM ETP 32 US S30, CATALOG 412331Z-0822-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL ERYTHROMYCIN EM 256 US S30, CATALOG 412333Z-0823-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL IMIPENEM IP 32 US S30, CATALOG 412373Z-0825-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL LEVOFLOXACIN LE 32 US S30, CATALOG 412392Z-0826-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL MEROPENEM MP 32 US S30, CATALOG 412401Z-0827-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL MINOCYCLINE MC 256 US S30, CATALOG 412407Z-0828-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL RIFAMPICIN RI 32 US S30, CATALOG 412449Z-0829-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL TOBRAMYCIN TM 256 US S30, CATALOG 412478Z-0830-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL VANCOMYCIN VA 256 US S30, CATALOG 412486Z-0831-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL CEFTOLOZANE/TAZO C/T US S30, CATALOG 414445Z-0841-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL CEFTAZIDIM/AVIBACTAM US S30, CATALOG 419046Z-0846-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927Z-0849-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL ERAVACYCLINE ERV US S30, CATALOG 421553Z-0851-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL ETEST MEROPENEM/VABORBACTAM MEV US S30, CATALOG 421560Z-0852-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL ETEST MEROPENEM MP M100 US, CATALOG 423786Z-0859-2023 · JWY | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.